Asaf Danziger

Board Member

NovoCure Ltd (NVCR)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

NovoCure Ltd (NVCR)
Board Member

Proxy statement

Current
2012-01-01–present
NovoCure Ltd (NVCR)
CEO

Proxy statement

Start not stated–2025-01-01
NovoCure Ltd (NVCR)
CEO

Proxy statement

Start not stated–2025-01-01

Company network

Recorded roles and earnings-call appearances connecting this person to public companies.

NVCR

Current role

Board Member, CEO

2012-01-01–present

18 calls Latest call 2024-10-30

View earnings calls

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	NovoCure Ltd (NVCR)	Chief Executive Officer	$763,782	$0	$0	$0	$508,338	$266,968	$1,539,088
2023	NovoCure Ltd (NVCR)	Chief Executive Officer	$756,093	$0	$0	$0	$507,742	$257,191	$1,521,026
2022	NovoCure Ltd (NVCR)	Chief Executive Officer	$830,649	$0	$0	$579,437	$584,220	$284,645	$2,278,951
2021	NovoCure Ltd (NVCR)	Chief Executive Officer	$876,086	$0	$0	$0	$0	$284,150	$1,160,236
2020	NovoCure Ltd (NVCR)	Chief Executive Officer	$781,868	$0	$6,946,850	$0	$934,607	$293,379	$8,956,704
2019	NovoCure Ltd (NVCR)	Chief Executive Officer	$702,295	$0	$1,155,020	$4,472,183	$693,139	$293,970	$7,316,607
2018	NovoCure Ltd (NVCR)	Chief Executive Officer	$692,675	$0	$587,505	$2,359,400	$644,266	$286,448	$4,570,294
2017	NovoCure Ltd (NVCR)	Chief Executive Officer	$698,439	—	$1,144,000	$1,533,150	$643,668	$292,331	$4,311,588

Recent activity

Earnings-call appearances and filed executive appointments or departures, newest first.

Executive change Appointed: director NovoCure Ltd (NVCR)
2026-06-03
Executive change Appointed: director NovoCure Ltd (NVCR)
2025-06-04
Executive change Resigned: Chief Executive Officer NovoCure Ltd (NVCR)
2025-01-01
Executive change Retired: Chief Executive Officer NovoCure Ltd (NVCR)
2025-01-01
Executive change Retired: Chief Executive Officer (CEO) NovoCure Ltd (NVCR)
2025-01-01
Earnings call NovoCure Ltd Q3 FY2024 Earnings Call NovoCure Ltd (NVCR)
2024-10-30
Earnings call NovoCure Ltd Q2 FY2024 Earnings Call NovoCure Ltd (NVCR)
2024-07-25
Executive change Appointed: director NovoCure Ltd (NVCR)
2024-06-05
Earnings call NovoCure Ltd Q1 FY2024 Earnings Call NovoCure Ltd (NVCR)
2024-05-02
Earnings call NovoCure Ltd Q4 FY2023 Earnings Call NovoCure Ltd (NVCR)
2024-02-22
Earnings call NovoCure Ltd Q3 FY2023 Earnings Call NovoCure Ltd (NVCR)
2023-10-26
Earnings call NovoCure Ltd Q2 FY2023 Earnings Call NovoCure Ltd (NVCR)
2023-07-27

Show 12 earlier activities

Earnings call NovoCure Ltd Q1 FY2023 Earnings Call NovoCure Ltd (NVCR)
2023-05-04
Earnings call NovoCure Ltd Q4 FY2022 Earnings Call NovoCure Ltd (NVCR)
2023-02-23
Earnings call NovoCure Ltd Q3 FY2022 Earnings Call NovoCure Ltd (NVCR)
2022-10-27
Earnings call NovoCure Ltd Q2 FY2022 Earnings Call NovoCure Ltd (NVCR)
2022-07-28
Earnings call NovoCure Ltd Q4 FY2021 Earnings Call NovoCure Ltd (NVCR)
2022-02-24
Earnings call NovoCure Ltd Q3 FY2021 Earnings Call NovoCure Ltd (NVCR)
2021-10-28
Earnings call NovoCure Ltd Q2 FY2021 Earnings Call NovoCure Ltd (NVCR)
2021-07-29
Earnings call NovoCure Ltd Q1 FY2021 Earnings Call NovoCure Ltd (NVCR)
2021-04-29
Earnings call NovoCure Ltd Q4 FY2020 Earnings Call NovoCure Ltd (NVCR)
2021-01-11
Earnings call NovoCure Ltd Q3 FY2020 Earnings Call NovoCure Ltd (NVCR)
2020-10-29
Earnings call NovoCure Ltd Q2 FY2020 Earnings Call NovoCure Ltd (NVCR)
2020-07-30
Earnings call NovoCure Ltd Q1 FY2020 Earnings Call NovoCure Ltd (NVCR)
2020-04-30